Glaxo Eyes IPO For HIV Unit As Part Of Restructuring Plan
GlaxoSmithKline PLC said Wednesday that it is considering launching an initial public offering for part of its HIV joint venture ViiV Healthcare as it embarks on an ambitious recovery plan to...To view the full article, register now.
Already a subscriber? Click here to view full article